Common Health Issues in Australian Shepherd: A Complete Guide
This comprehensive guide covers the most important health concerns specific to the Australian Shepherd, including breed-related genetic conditions (MDR1 sensitivity, PRA, hip dysplasia), common diseases, recommended preventive screenings (OFA, ophthalmology, DNA tests), lifespan factors, and practical veterinary recommendations for owners.
Overview
The Australian Shepherd is a high-energy herding breed known for intelligence, athleticism, and distinctive coat patterns including merle, black, red, and combinations with white and tan markings. While generally healthy with a typical lifespan of 12–15 years, Australian Shepherds carry a set of breed-specific health risks and genetic conditions that owners and breeders should understand. Early screening, responsible breeding, and routine veterinary care can reduce the risk and improve outcomes for many of these problems.
Breed profile and lifespan
- Size: medium (males typically 20–23 inches at the shoulder; females typically 18–21 inches).
- Typical weight range: about 35–65 pounds, depending on sex and build.
- Lifespan: commonly 12–15 years when cared for properly; some individuals live longer with attentive management.
Common genetic and breed-associated conditions
Australian Shepherds are predisposed to several hereditary and breed-associated conditions. Many are well characterized; genetic testing and structural screening are available for several of them.
1. MDR1 (ABCB1) Drug Sensitivity
- What it is: A mutation in the ABCB1 gene (formerly called MDR1) affects how certain drugs are processed, leading to increased sensitivity and neurotoxicity with medications like ivermectin (at high doses), loperamide, certain chemotherapy agents, and some sedatives.
- Why it matters for Australian Shepherds: The MDR1 mutation is common in herding breeds, including Australian Shepherds. Affected dogs may have severe reactions to normal drug doses.
- Recommendation: All Australian Shepherds should be DNA tested for MDR1. Owners and veterinarians should keep a list of contraindicated drugs and use alternatives when a dog is MDR1-affected or unknown.
2. Progressive Retinal Atrophy (PRA) and Other Eye Disorders
- What it is: PRA is a group of inherited retinal degenerative diseases leading to progressive vision loss and eventual blindness. Australian Shepherds are also at risk for cataracts and other inherited retinal disorders.
- Why it matters: Vision loss affects quality of life and may not be apparent until the disease is advanced.
- Recommendation: Annual or biannual ophthalmic exams by a veterinary ophthalmologist, and submitting results to OFA (or equivalent) for eye-certification. Consider DNA tests that identify PRA mutations known in your pedigree.
3. Deafness (Congenital and Sensorineural)
- What it is: Some Australian Shepherds—particularly double merles or dogs with extensive white markings around the head—are at increased risk of congenital deafness.
- Why it matters: Deafness affects training and safety (e.g., recall). Detection early allows adaptation of training techniques.
- Recommendation: BAER (Brainstem Auditory Evoked Response) testing can detect congenital deafness in puppies. Responsible breeders avoid producing double merle litters by not breeding two merle-patterned dogs.
4. Hip and Elbow Dysplasia
- What it is: Hip dysplasia is an abnormal formation of the hip joint that can lead to arthritis and decreased mobility. Elbow dysplasia affects the elbow joint.
- Why it matters: These are common orthopedic problems in many medium and large breeds and can cause chronic pain and lameness.
- Recommendation: Radiographic screening (OFA or PennHIP) for hips and OFA assessment of elbows for breeding animals. Maintain lean body condition and avoid high-impact exercise while joints are maturing (until around 12–18 months). Early diagnosis enables conservative or surgical management.
5. Epilepsy and Seizure Disorders
- What it is: Idiopathic epilepsy and some hereditary seizure disorders occur in Australian Shepherds.
- Why it matters: Seizures require veterinary diagnosis and often long-term medication or management.
- Recommendation: If seizures appear, pursue a full workup (bloodwork, metabolic screening, possibly MRI/CSF) and work with a veterinary neurologist if needed. Breeding animals with idiopathic epilepsy should be removed from breeding plans.
6. Hypothyroidism
- What it is: Inadequate thyroid hormone production can lead to weight gain, hair coat changes, lethargy, and skin issues.
- Why it matters: Hypothyroidism is manageable with daily thyroid replacement if diagnosed.
- Recommendation: Evaluate thyroid function in dogs with clinical signs. Many suspected cases require repeat testing and referral to a veterinarian for appropriate diagnostics.
7. Degenerative Myelopathy (DM)
- What it is: A progressive spinal cord disease causing hind limb weakness that can lead to paralysis.
- Why it matters: The SOD1 mutation associated with DM has been identified in multiple breeds, including Australian Shepherds.
- Recommendation: Genetic testing for SOD1 variants can identify risk. Manage affected dogs with physical therapy, mobility support, and palliative care.
Preventive screening and testing recommendations for Australian Shepherds
For breeders and owners committed to optimal health, the following screening regimen is widely recommended:
- MDR1 genetic test (DNA): universal for Australian Shepherds.
- Eye exams by a board-certified veterinary ophthalmologist, annually or at intervals recommended by your vet; submit results to OFA/eye registry.
- Hip evaluation via OFA or PennHIP prior to breeding; institute conservative management for pets with early signs.
- Elbow radiographs evaluated by OFA for breeding stock.
- PRA/Cataract genetic testing when relevant mutations are available for the pedigree.
- BAER hearing test for puppies, especially in merle or extensive-white-marked pups.
- SOD1 test for degenerative myelopathy risk where appropriate.
Vaccination, parasite control and routine care
Australian Shepherds require the same core preventive care as other dogs: core vaccinations, heartworm prevention, flea/tick control, and regular fecal testing for intestinal parasites. Because Australian Shepherds are often active outdoors and in contact with livestock or wildlife, consistent parasite prevention and environmental management are important.
Lifestyle and management to reduce disease risk
- Maintain optimal body condition: Lean dogs have lower risk of orthopedic disease progression and metabolic complications.
- Controlled growth: Avoid high-calorie diets and excessive jumping or high-impact exercise while puppies’ growth plates are closing.
- Mental and physical exercise: Regular activity reduces stress-related behaviors but avoid repetitive high-impact activity in young dogs.
- Dental care: Dental disease can affect systemic health; implement tooth brushing and professional cleanings as needed.
When to see the veterinarian
Seek veterinary attention for any of the following:
- Changes in gait, stiffness, or lameness.
- Vision changes, bumping into objects, or dilated pupils.
- Seizures or unexplained collapse.
- Sudden changes in behavior, appetite, or weight.
- Signs of drug sensitivity (neurologic signs) after exposure to medications—particularly in dogs with unknown MDR1 status.
Working with breeders and selecting a healthy Australian Shepherd
If you are selecting a puppy, ask breeders for documentation of health clearances for both parents: MDR1 test results, OFA hip/elbow certificates or PennHIP scores, ophthalmology exam results, BAER hearing tests (if performed), and any relevant genetic tests (PRA, SOD1). Responsible breeders avoid merle-to-merle pairings to reduce the risk of double-merle offspring that are at high risk of deafness and severe ocular defects.
Prognosis and long-term management
Many Australian Shepherds with diagnosed conditions (hip dysplasia managed medically or surgically; PRA detected early; MDR1 carriers given drug alternatives) can live full, active lives with appropriate management. Early detection, preventive screening, and owner education are key to maintaining quality of life.
Practical veterinary recommendations (summary)
- Test for MDR1 and other relevant DNA mutations early.
- Arrange ophthalmic exams annually or as recommended.
- Screen hips and elbows via OFA or PennHIP prior to breeding and monitor athletic dogs for signs of joint issues.
- BAER test merle puppies for congenital deafness.
- Maintain ideal body weight, provide joint supplements when indicated, and prevent high-impact exercise during growth.
- Keep an up-to-date list of safe/unsafe medications for MDR1-affected dogs and discuss alternatives with your veterinarian.
FAQ
Q: At what age should I test my Australian Shepherd for MDR1?
A: MDR1 DNA testing can be performed at any age, including on puppies. Many breeders test parents and puppies before sale so owners and veterinarians know the dog’s status early.Q: How common is hip dysplasia in Australian Shepherds?
A: Hip dysplasia occurs at variable rates depending on lineage and breeding practices. With responsible screening (OFA/PennHIP) and selection, incidence can be reduced. Early weight control and activity management help minimize clinical problems.Q: Are merle Australian Shepherds more at risk for health problems?
A: Merle coat pattern itself is linked to increased risk when two merle dogs are bred (double merle), which can produce deafness and severe eye defects. Single merles may have higher rates of certain ocular anomalies and should receive routine ophthalmic screening.Q: What is the life expectancy of an Australian Shepherd with PRA?
A: PRA leads to progressive vision loss but not necessarily reduced lifespan. With adaptations and environmental adjustments, dogs can remain happy and mobile. Management focuses on ensuring safety and maintaining quality of life.Q: What should I tell my vet if my Australian Shepherd needs medication?
A: Inform your veterinarian of your dog’s MDR1 status if known. If unknown, request MDR1 testing before administering drugs known to cause sensitivity in herding breeds. Provide a full list of current medications and supplements.Frequently Asked Questions
At what age should I test my Australian Shepherd for MDR1?
MDR1 DNA testing can be performed at any age, including on puppies. Many breeders test parents and puppies before sale so owners and veterinarians know the dog’s status early.
How common is hip dysplasia in Australian Shepherds?
Hip dysplasia occurs at variable rates depending on lineage and breeding practices. With responsible screening (OFA/PennHIP) and selection, incidence can be reduced. Early weight control and activity management help minimize clinical problems.
Are merle Australian Shepherds more at risk for health problems?
Merle coat pattern itself is linked to increased risk when two merle dogs are bred (double merle), which can produce deafness and severe eye defects. Single merles may have higher rates of certain ocular anomalies and should receive routine ophthalmic screening.
What is the life expectancy of an Australian Shepherd with PRA?
PRA leads to progressive vision loss but not necessarily reduced lifespan. With adaptations and environmental adjustments, dogs can remain happy and mobile. Management focuses on ensuring safety and maintaining quality of life.
What should I tell my vet if my Australian Shepherd needs medication?
Inform your veterinarian of your dog’s MDR1 status if known. If unknown, request MDR1 testing before administering drugs known to cause sensitivity in herding breeds. Provide a full list of current medications and supplements.
Related Health Conditions
Reviewed by: AllPets Veterinary Advisory Board on July 3, 2026